Mona S. El‐Zoghbi

From triazolophthalazines to triazoloquinazolines: A bioisosterism-guided approach toward the identification of novel PCAF inhibitors with potential anticancer activity

Mohamed H. El‐Shershaby, Adel Ghiaty, Ashraf H. Bayoumi et al. · Bioorganic & Medicinal Chemistry · 2021 · 67 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14

1,2,4-Triazolo[4,3-<i>c</i>]quinazolines: a bioisosterism-guided approach towards the development of novel PCAF inhibitors with potential anticancer activity

Mohamed H. El‐Shershaby, Adel Ghiaty, Ashraf H. Bayoumi et al. · New Journal of Chemistry · 2021 · 48 citations

Pharmacy, Medicinal Chemistry, Pharmacology +5

In vivo‐ and in silico‐driven identification of novel synthetic quinoxalines as anticonvulsants and AMPA inhibitors

Hamada S. Abulkhair, Salwa Elmeligie, Adel Ghiaty et al. · Archiv der Pharmazie · 2021 · 46 citations

Pharmacy, Medicinal Chemistry, Pharmacology +13

Potential antiviral and anticancer effect of imidazoles and bridgehead imidazoles generated by HPV-Induced cervical carcinomas via reactivating the P53/ pRb pathway and inhibition of CA IX

Aisha Y. Hassan, Samiha A. El‐Sebaey, Moshira A. El Deeb et al. · Journal of Molecular Structure · 2021 · 31 citations

Medicine, Oncology, Pharmacology +17

Utilization of cyanopyridine in design and synthesis of first-in-class anticancer dual acting PIM-1 kinase/HDAC inhibitors

Amr K. A. Bass, El-Shimaa M. Nageeb, Mona S. El‐Zoghbi et al. · Bioorganic Chemistry · 2021 · 31 citations

Pharmacy, Medicinal Chemistry, Oncology +8